Build status - In Progress

Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer
Recruiting
18 years - 99 years
All
Phase 1
200 participants needed
1 Location

Brief description of study

This study will evaluate the efficacy of investigational drug treatments combinations in patients with metastatic colorectal cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Metastatic Colorectal Cancer
  • Age: 18 years - 99 years
  • Gender: All

Male and female participants ≥ 18 years of age, Metastatic colorectal adenocarcinoma

Updated on 04 Aug 2024. Study ID: 849263

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center